Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

WMIF25 – World Medical Innovation Forum, Sept. 15-17, 2025, Boston

Clinical experts, industry, investment leaders

https://2025.worldmedicalinnovation.org/

 

I, Aviva Lev-Ari, PhD, RN had covered the WMIF Conference since it was launched 11 years ago, including WMIF24.

• Part Two: List of BioTech Conferences 2013 to Present
• Part Three: Conference eProceedings DELIVERABLES & Social Media Analytics

 

#WMIF19 was a special conference with the focus on AI in Medicine

The #WMIF19 Influencers via @symplur‘s #Healthcare Hashtags http://bit.ly/WMIF19 – By Mentions and By Tweets Ranked #4: @pharma_BI and #2: @AVIVA1950, respectively. Ranked #3 via NodeXL’s Betweenness Centrality http://bit.ly/2KB6cPN

https://pharmaceuticalintelligence.com/2019/04/13/the-wmif19-influencers-via-symplurs-healthcare-hashtags-http-bit-ly-wmif19-by-mentions-and-by-tweets-ranked-4-pharma_bi-and-2-aviva1950-respectively-ranked-3-via-node/

 

9/15/2025 – 9/17/2025 – I did not attended In-person WMIF25.

• I was invited to cover the event in real time, as follows:

From: “Doyle, Tracy” <tdoyle5@mgb.org>
Date: Wednesday, August 20, 2025 at 11:07 AM
Cc: “Yiannacopoulos, John” <john.yiannacopoulos@bofa.com>, “Doyle, Tracy” <tdoyle5@mgb.org>
Subject: Media Invite: World Medical Innovation Forum, Sept. 15-17, Boston — Clinical experts, industry, investment leaders

Media Invite: World Medical Innovation Forum: Monday, Sept. 15 — Wednesday, Sept. 17, Boston – Innovation at Scale

 

VIDEOS from this Conference on Youtube.com

https://www.youtube.com/results?search_query=WMIF

 

Selected Speakers:

Peter Arduini

CEO, GE HealthCare

 

Eliav Barr, MD

 

SVP, Chief Medical Officer and Head of Global Clinical Development, Merck

Meredith Fisher, PhD

 

Partner, Mass General Brigham Ventures

Jean-François Formela, MD

 

Partner, Atlas Venture

Adele Gulfo

 

President & CEO, Biopharma Strategies and Insights

Jason Hafler, PhD

 

Managing Director, Sanofi Ventures

Rajiv Kaul

 

Portfolio Manager, Fidelity Investments

Paul LaViolette

 

Managing Partner, SV Health Investors

David Liu, PhD

 

Richard Merkin Professor; Director, Merkin Institute of Transformative Technologies in Healthcare, Broad Institute

Paul Matsen

 

Chief Marketing and Communications Officer, Cleveland Clinic

Michael Mihm, PhD

 

Asset Lead, Astellas Pharma

Bernd Montag, PhD

 

CEO, Siemens Healthineers

Michael Quigley, PhD

 

Chief Scientific Officer, Global Head of Research, Sanofi

John Reed, MD, PhD

 

Executive Vice President, Innovation Medicine, R&D, Johnson & Johnson

David Reese, MD

 

EVP & Chief Technology Officer, Amgen

David Rhew, MD

 

Global Chief Medical Officer & VP Healthcare, Microsoft

Jay Rughani

 

Investing Partner, Andreessen Horowitz

Gaurav Singal, MD

 

Independent advisor and investor

Ariel Stern, PhD

 

Alexander von Humboldt Professor, Hasso Plattner Institute

Ricky Sun, PhD

 

Partner, Bain Capital

Andrew Trister, MD, PhD

 

Chief Medical and Scientific Officer, Verily [Google]

Christopher Viehbacher

 

CEO, Biogen

Erin Xie, PhD

 

Managing Director, BlackRock

 

1:1 firesides and panels with top experts including:

Amy Abernethy MD, PhD, Cofounder, Highlander Health

Peter Arduini, CEO, GE HealthCare

Jeffrey Balser MD, PhD, CEO, Vanderbilt University Medical Center

Eliav Barr MD, Chief Medical Officer, Merck

Tom Frohlich, CEO, Jade Biosciences

David Hyman MD, Chief Medical Officer, Eli Lilly

Rajiv Kaul, Portfolio Manager, Fidelity

Anne Klibanski MD, CEO, Mass General Brigham

Robert Langer ScD, Institute Professor, MIT

Anu Madgavkar, Partner, McKinsey Global Institute

Kevin Mahoney, CEO, UPenn Health System

Paul Matsen, Chief Marketing and Communications Officer, Cleveland Clinic

Bernd Montag PhD, CEO, Siemens Healthineers

Dinesh Patel, PhD, CEO, Protagonist Therapeutics

Xiayang Qiu, PhD, CEO, Regor Therapeutics

Mike Quigley, CSO, Sanofi

David Rhew, Global Chief Medical Officer & VP Healthcare, Microsoft

Ken Song, MD, CEO, Candid Therapeutics

David Sontag PhD, CEO, Layer Health

Chris Viehbacher, CEO, Biogen

 

Government and regulatory experts including:

Larry Bucshon MD, Senior Policy Advisor, Holland & Knight; Former U.S. Representative (Indiana, 2011–2025)

Robert Califf MD, Instructor in Medicine, Duke University; Former Commissioner, U.S. Food and Drug Administration

Susan Collins, Senior U.S. Senator from Maine

Maura Healey, Governor of the Commonwealth of Massachusetts

Susan Monarez PhD, Director, Centers for Disease Control and Prevention

 

Deep-Dive KOL and Focused Sessions including:

• Emerging Treatments: Cancer, Cardiovascular Disease, Obesity & Metabolic Diseases
• AI at the Bedside — Physician Co-Pilots
• Upending the U.S. Care Model
• Antimicrobial Resistance – An Urgent, Global Crisis
• The Silver Tsunami – Unprecedented and Unceasing
• Institutional Investor Perspectives
• Innovations in Disability Technology
• Consumerism in Healthcare
• Tackling High-Priority Health Challenges in Under-Served Communities
• Sleep – the Future of a Busy Market
• Gene Editing – Precision Medicine in Practice
• Hospital Venture Investing

 

Leading biotech and venture execs from companies such as:

• Andreessen Horowitz
• ArrePath
• Bain Capital Life Sciences
• Caris Life Sciences
• Enable Ventures
• Fidelity Investments
• Intellia Therapeutics
• Layer Health
• Lightspeed Venture Capital
• Novo Holdings Venture Investments
• Viz.ai

Exclusive programming:  

• First Look – 19 rapid-fire presentations on the latest research from leading Mass General Brigham scientists
• Big Ideas – 100+ key opinion leaders in healthcare weigh in on solving the top un-met clinical needs in medicine today
• Emerging Tech Zone – Hands-on exploration of some of the latest digital and AI-based healthcare technologies